The American biotechnology company Windtree Therapeutics has announced a significant entry into the digital asset market, planning to allocate up to $700 million for the acquisition of BNB — the native cryptocurrency of the BNB Chain ecosystem.
This is reported by Finway
Details of the Financing and Investment Strategy
Windtree Therapeutics has entered into two agreements to raise up to $520 million to implement its strategy for building cryptocurrency reserves. A substantial portion of this amount, specifically 99%, will be used for the purchase of BNB. The primary agreement involves opening a credit line (ELOC) of up to $500 million through the sale of common stock in the company. Additionally, the company has entered into a $20 million agreement with Build and Build Corp — an organization founded by financiers Patrick Horsman, Joshua Kruger, and Jonathan Pash, supported by leading market players such as Kraken, Galaxy Digital, Off The Chain Capital, and others.
“We are excited to implement these new tools for future BNB acquisitions as part of our cryptocurrency holding strategy. Subject to shareholder approval, the ability to raise additional funds for the purchase of BNB is crucial to our strategy,” commented Windtree CEO Jed Latkin.
Terms of the Agreement and Prospects
It is worth noting that Windtree will be able to utilize the credit line only after shareholders approve the decision to increase the number of issued common shares. The company positions this move as part of an asset diversification strategy focused on digital currencies with high growth potential.
Patrick Horsman, Director of Build and Build Corp, emphasized that integrating BNB into Windtree’s treasury is a progressive approach to creating additional value for the company.
It is worth recalling that BNB recently reached an all-time high, surpassing the $800 mark, which only underscores the growing appeal of this cryptocurrency for large institutional investors.